Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Essential Hypertension”

83 trials

Showing 20 of 83 results

Large-scale testing (Phase 3)Study completedNCT00151827
What this trial is testing

Olmesartan Medoxomil in Hypertension and Renal Impairment

Who this might be right for
Essential HypertensionRenal Impairment
Sankyo Pharma Gmbh 393
Not applicableNot Yet RecruitingNCT07577323
What this trial is testing

Safety and Efficacy Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Modulation in Patients With Mild Essential Hypertension

Who this might be right for
Essential Hypertension
Xuanwu Hospital, Beijing 60
Large-scale testing (Phase 3)Study completedNCT00257491
What this trial is testing

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 29
Post-approval studies (Phase 4)UnknownNCT02641821
What this trial is testing

Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

Who this might be right for
Hypertension
Peking University First Hospital 700
Not applicableStudy completedNCT00638911
What this trial is testing

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 33,247
Early research (Phase 1)Looking for participantsNCT07803835
What this trial is testing

Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension

Who this might be right for
Essential HypertensionHealthy Volunteers
Shanghai Minwei Biotechnology Co., Ltd 46
Very early researchStudy completedNCT05095350
What this trial is testing

Effect of Probiotics on Primary Hypertension

Who this might be right for
Hypertension
Chinese Academy of Medical Sciences, Fuwai Hospital 115
Post-approval studies (Phase 4)Looking for participantsNCT06093932
What this trial is testing

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

Who this might be right for
Hypertension,Essential
Xiyuan Hospital of China Academy of Chinese Medical Sciences 100
Large-scale testing (Phase 3)Study completedNCT05359068
What this trial is testing

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd 957
Post-approval studies (Phase 4)Study completedNCT00147563
What this trial is testing

Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT

Who this might be right for
Hypertension
Pfizer 34
Large-scale testing (Phase 3)Study completedNCT00262236
What this trial is testing

Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension

Who this might be right for
Hypertension
Novartis 693
Large-scale testing (Phase 3)Study completedNCT00367094
What this trial is testing

Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 296
Post-approval studies (Phase 4)UnknownNCT06501651
What this trial is testing

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Who this might be right for
Essential HypertensionType 2 DiabetesNephropathy
Sichuan Academy of Medical Sciences 297
Testing effectiveness (Phase 2)Study completedNCT01303783
What this trial is testing

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension

Who this might be right for
Hypertension, Essential
Bayer 1,381
Large-scale testing (Phase 3)Study completedNCT02183701
What this trial is testing

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 715
Post-approval studies (Phase 4)Study completedNCT02031861
What this trial is testing

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Shyndec Pharmaceutical Co., Ltd. 38
Post-approval studies (Phase 4)Study completedNCT00130156
What this trial is testing

Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

Who this might be right for
High Blood Pressure
Eisai Inc. 93
Early research (Phase 1)Study completedNCT00424541
What this trial is testing

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 34
Testing effectiveness (Phase 2)Study completedNCT00710372
What this trial is testing

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Who this might be right for
Mild Essential HypertensionModerate Essential Hypertension
Cytos Biotechnology AG 83
Testing effectiveness (Phase 2)Study completedNCT00759551
What this trial is testing

Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

Who this might be right for
Hypertension
Takeda 555
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation